A case of herbicide-induced acute fibrinous and organizing pneumonia?

Shengsong Chen1, Hong Zhou1, Lingling Yu2

  • 1Department of Respiratory and Critical Care Medicine, Jiangxi Provincial People's Hospital, No.92 Aiguo Road, Nanchang, 330006, China.

BMC Pulmonary Medicine
|December 15, 2017
PubMed
Abstract

Insights

Acute fibrinous and organizing pneumonia (AFOP) is a rare lung condition. Early diagnosis and glucocorticoid treatment are crucial for recovery when standard antibiotics fail.

Area of Science:

  • Pulmonology
  • Pathology
  • Radiology

Background:

  • Acute fibrinous and organizing pneumonia (AFOP) is a rare histopathological diagnosis.
  • Understanding AFOP requires integrating clinical, imaging, and pathological findings.
  • This case highlights the diagnostic challenges of AFOP.

Observation:

  • A 50-year-old male presented with symptoms mimicking community-acquired pneumonia (CAP).
  • Initial empiric antibacterial therapy for suspected CAP was ineffective.
  • Chest CT revealed a high-density shadow in the right lung lobe.

Findings:

  • Percutaneous lung biopsy confirmed the diagnosis of AFOP.
  • Pathological findings were consistent with AFOP.
  • Glucocorticoid therapy led to symptom relief and radiological improvement.

Implications:

  • AFOP can be misdiagnosed due to its non-specific presentation.
  • Consider AFOP in cases of refractory pneumonia despite antibacterial treatment.
  • Prompt diagnosis and appropriate treatment (e.g., glucocorticoids) are key for favorable outcomes in AFOP.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
939
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
837
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
930
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K